$SRE Cashflow Statement | Understand Stock

$SRE

$84.24 +$0.18 (0.21%) Close

$SRE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income
Less: Income from discontinued operations, net of income tax
Adjustments to reconcile net income to net cash provided by operating activities:
Regulatory disallowances
Depreciation and amortization
Deferred income taxes and investment tax credits
Impairment losses
Gain on sale of assets
Equity earnings
Foreign currency transaction (gains) losses, net
Share-based compensation expense
Fixed-price contracts and other derivatives
Bad debt expense
Other
Net change in working capital components:
Accounts receivable
Due to/from unconsolidated affiliates, net
Income taxes receivable/payable, net
Inventories
Other current assets
Accounts payable
Regulatory balancing accounts, net
Reserve for Aliso Canyon costs
Other current liabilities
Intercompany activities with discontinued operations, net

Insurance receivable for Aliso Canyon costs

Distributions from investments
Wildfire fund, current and noncurrent
Reserve for Aliso Canyon costs, noncurrent
Changes in other noncurrent assets and liabilities, net
Net cash used in discontinued operations
Net cash provided by operating activities

Net cash used in investing activities
Expenditures for property, plant and equipment
Expenditures for investments
Proceeds from sale of assets
Return on investments
Purchases of nuclear decommissioning and other trust assets
Proceeds from sales of nuclear decommissioning and other trust assets
Advances to unconsolidated affiliates
Repayments of advances to unconsolidated affiliates
Disbursement for note receivable
Intercompany activities with discontinued operations, net
Other
Net cash provided by discontinued operations
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Common dividends paid
Preferred dividends paid
Issuances of preferred stock, net
Redemption of preferred stock
Repurchases of common stock
Issuances of debt (maturities greater than 90 days)
Payments on debt (maturities greater than 90 days) and finance leases
Increase (decrease) in short-term debt, net
Advances from unconsolidated affiliates
Contributions from contingently redeemable noncontrolling interest, net of transaction costs
Proceeds from investor equity subscription
Proceeds from sales of noncontrolling interests, net
Contributions from noncontrolling interests
Purchases of noncontrolling interests
Distributions to noncontrolling interests
Termination of interest rate and settlement of cross-currency swaps
Other
Net cash provided by discontinued operations
Net cash (used in) provided by financing activities

Effect of exchange rate changes in discontinued operations
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(Decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, January 1
Cash, cash equivalents and restricted cash, December 31
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES
Interest payments, net of amounts capitalized
Income tax payments, net of refunds
Cash Flow, Noncash Investing and Financing Activities Disclosure
Accrued commercial paper proceeds
Accrued interest receivable from unconsolidated affiliate
Contribution to Cameron LNG JV
Distribution from Cameron LNG JV
Increase in Cameron LNG JV investment for guarantee
Accrued interest receivable capitalized to note receivable
Repayments of advances from unconsolidated affiliate in lieu of distributions
Accrued capital expenditures for PP&E
Capital expenditures reclassified from other assets to PP&E
Increase in ARO capitalized to PP&E
Equitization of long-term debt for deficit held by NCI
Accrued purchase price adjustment for sale of NCI
Issuance of common stock in exchange for NCI and related AOCI
Conversion of mandatory convertible preferred stock
Increase in finance lease obligations capitalized to PP&E
Derecognized PP&E for net investment in sales-type lease
Amortized debt issuance costs capitalized to PP&E
Unamortized debt issuance costs reclassified from noncurrent assets to long-term debt
Accrued interest payable capitalized to due to unconsolidated affiliate
Change in equity related to allocation of interests, net of tax
Preferred deemed dividends
Dividends declared but not paid
Preferred stock
Common Stock
Common dividends issued in stock
Net exercise of stock options
Contributions from NCI

Comments